Laboratory Leadership, Workforce Training and Management Development, Improving Public Health Laboratory Infrastructure
Active
- Assistance listing
- 93.065
- Agency
-
Centers for Disease Control and Prevention
Department of Health and Human Services
- Grant awards
- 34 $141,647,214 in federal obligations
Program facts
- Also known as
- Enhancing Disease Detection in Newborns: Building Capacity in Public Health Laboratories
- Assistance types
-
- Cooperative Agreement
- Project Grant
- Treasury account
-
- 75-0943-0-1-550
- More information
Program details come from SAM.gov Assistance Listings. Updated . Grant award figures come from USAspending.gov.
About this program
The Centers for Disease Control and Prevention (CDC) funds laboratory leadership, workforce training, and newborn screening infrastructure development under Assistance Listing 93.065, with the most recent grant award disbursed on August 1, 2024.
The program funds capacity-building activities in state and territorial public health laboratories focused on implementing newborn screening for conditions recommended by the HHS Advisory Committee on Heritable Disorders in Newborns and Children, workforce training for public health laboratory professionals, and epidemiology and laboratory capacity strengthening for infectious disease surveillance and response. Recent awards have supported implementation of advanced screening technologies including next-generation sequencing and high-resolution mass spectrometry, data harmonization initiatives, healthcare-associated infection surveillance, and technical assistance to international partners on pandemic preparedness and infectious disease control.
The CDC dominates funding under this listing, obligating $123.1 million across 18 awards; a secondary line within the program contributed $5.4 million across 14 awards. The assistance-type mix is predominantly Cooperative Agreements (91% of awards) with smaller shares of Project Grants (9%). Combined federal dollars obligated total $141.4 million across 34 awards spanning 2008 to 2024. Recent awards range widely in scale: a $13.6 million cooperative agreement with Cleveland (Ohio) on respiratory virus vaccine effectiveness (September 2022); a $9.5 million cooperative agreement with Laos PDR Ministry of Health on global health security strengthening (September 2020); and smaller state-level awards of $500 thousand to $950 thousand for newborn screening implementation and data harmonization. Award cadence has varied, ranging from 7 awards in 2018 down to 1 award in 2022, with 2 awards in 2024.
The most recent posted opportunity, CDC-RFA-EH-24-0044 ("Centers of Excellence to Enhance Disease Detection in Newborns"), closed on June 4, 2024. That NOFO sought to establish newborn screening Centers of Excellence to develop infrastructure for advanced technologies, implement second and third-tier testing platforms, and incorporate bioinformatics for data analysis, with eligibility unrestricted to all applicant types. Earlier opportunities under the program have typically supported up to eight state or territorial laboratories per cycle to add HHS-recommended screening conditions to their panels, with project periods ranging from two to five years and initial budget periods of twelve months. Applicants must represent or partner with established state or territorial newborn screening programs to be eligible.
Objective and description
- Objective
This program will increase the capacity and capability of state and territorial newborn screening laboratories to test for newborn screening conditions as recommended by the U.S. Department of Health and Human Services (HHS) Advisory Committee on Her
Eligibility
- Applicant eligibility
NOFOs published under this listing are typically unrestricted. See the published NOFOs on grants.gov for additional information on eligibility.
- Beneficiary eligibility
This project represents the front line defense against health threats to the nation's public. The nation's public is the ultimate recipient of benefits from this program.
- Credentials and documentation
Any required credentials and/or documentation will be identified in the specific Notice of Funding Opportunity (NOFO) for this Assistance Listing.
- Uses of assistance
The purpose of the program is to enhance the work of public health laboratories in the U.S. and abroad. The program aims to promote quality public health laboratory practice, improve public health laboratory infrastructure, strengthen the public health laboratory system, and to develop a well-trained public health laboratory workforce in the U.S. and globally. It also aims to ensure laboratory preparedness for emerging infectious diseases or other biologic and chemical public health threats, promote technology transfer to ensure up-to-date technologies for the testing laboratory, and enhance communication linkages between state and local public health laboratories and the clinical laboratory testing community Improvement of public health laboratory infrastructure, state-of-the-art training for the nation's laboratorians to be prepared in dealing with public health threats, improving laboratory leadership capabilities, enhancing inter-laboratory communications.
- Length and time phasing of assistance
Financial assistance is provided for a 12-month budget period with a period of performance of up to five years subject to the availability of funds and satisfactory progress of the recipient.
How to apply
- Criteria for selecting proposals
Applications will be evaluated on the review criteria described in the Notice of Funding Opportunity Announcements (NOFOs). In general, the review and selection process of complete and responsive applications to the NOFO consists of determination of the scientific and technical merit by objective or peer review, availability of funds, and relevance of program priorities and the priorities of CDC.
- Award procedure
After review and approval, a Notice of Award (NoA) will be prepared and processed, along with appropriate notification to the public. Initial awards provide funds for the first budget period (usually 12 months) and the NoA will indicate support recommended for the remainder of the project period, allocation of Federal funds by budget categories, award requirements, and special conditions, if any.
- Deadlines
Check Grants.gov for any relevant NOFO information regarding processes for applying for assistance.
- Time to approval or disapproval
From two to three months.
- Renewals
Project period of performance is 1 to 5 years. After initial awards, and subject to availability of funds, projects may be continued non-competitively contingent upon satisfactory progress by the recipient (as documented in required reports) and the determination that continued funding is in the best interest of the Federal government.
Grant opportunities
Grant awards
Latest 10 of 34 listed here. See the rest on GovTribe.
Top recipients by federal obligations
| Rank | Recipient | Federal obligations | Share |
|---|---|---|---|
| 1 | Association Of Public Health Laboratories, Inc. (The) | $98,648,912 | 70% |
| 2 | Florida Department Of Health | $9,639,449 | 7% |
| 3 | University Hospitals Cleveland Medical Center | $8,984,354 | 6% |
| 4 | Ministry Of Health, Laos | $8,018,480 | 6% |
| 5 | National Opinion Research Center | $5,526,855 | 4% |
| 6 | University Of Massachusetts Medical School | $1,752,478 | 1% |
| 7 | Department Of State Health Services | $1,576,539 | 1% |
| 8 | Health Research, Inc. | $1,087,868 | 1% |
| 9 | Michigan Department Of Health And Human Services | $943,075 | 1% |
| 10 | State Of Georgia Department Of Public Health | $597,329 | <1% |
10 of 25 recipients listed here. See the rest on GovTribe.
Federal obligations by fiscal year
| Fiscal year | Federal obligations |
|---|---|
| FY2026 | $400,000 |
| FY2025 | $3,457,569 |
| FY2024 | $4,755,052 |
| FY2023 | $1,121,225 |
| FY2022 | $1,954,671 |
| FY2021 | $1,493,126 |
| FY2020 | $3,116,363 |
| FY2019 | $1,848,425 |
| FY2018 | $1,949,039 |
| FY2017 | $749,912 |
| FY2016 | $599,004 |
| FY2015 | $5,857,066 |
| FY2014 | $16,306,550 |
| FY2013 | $18,772,461 |
| FY2012 | $13,994,333 |
| FY2011 | $21,678,902 |
| FY2010 | $28,617,798 |
| FY2009 | $3,521,253 |
| FY2008 | $506,375 |
Show all 19
Quick answers
What is Assistance Listing 93.065?
Assistance Listing 93.065 is Laboratory Leadership, Workforce Training and Management Development, Improving Public Health Laboratory Infrastructure, a federal grant program run by Centers for Disease Control and Prevention (Department of Health and Human Services).
What is the CFDA number for Laboratory Leadership, Workforce Training and Management Development, Improving Public Health Laboratory Infrastructure?
Its CFDA number is 93.065: Assistance Listing numbers were called CFDA numbers before 2018.
How much funding has Assistance Listing 93.065 awarded?
34 grant awards under 93.065 have obligated $141,647,214 in federal funds to 25 recipients.
Who receives the most funding from 93.065?
The recipients obligated the most under Laboratory Leadership, Workforce Training and Management Development, Improving Public Health Laboratory Infrastructure are Association Of Public Health Laboratories, Inc. (The) ($98,648,912), Florida Department Of Health ($9,639,449) and University Hospitals Cleveland Medical Center ($8,984,354).
How much did 93.065 obligate in fiscal year 2025?
Grants under 93.065 obligated $3,457,569 in federal funds in fiscal year 2025.
Are there open grant opportunities under 93.065?
No opportunity listed under 93.065 is open now. The latest, Centers of Excellence to Enhance Disease Detection in Newborns, was posted on August 11, 2023.
On GovTribe
See this program's full record
- Every grant award and opportunity under it
- Funding by recipient, agency and assistance type
- Alerts for new opportunities
- Ask GovTribe AI about this program